Clinical Trial: Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Pilot Study of Oxaliplatin in Combination With Capecitabine in Adult Cancer Patients

Brief Summary:

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase I trial to study the effectiveness of combining oxaliplatin with capecitabine in treating patients who have colorectal, appendix, or small bowel cancer.